US pitch for German COVID-19 vaccine maker prompts anger

17-03-2020

Edward Pearcey

US pitch for German COVID-19 vaccine maker prompts anger

rawf8 / Shutterstock.com

German authorities have reacted angrily to media reports that US President Donald Trump offered $1 billion to CureVac, a Germany-based company seeking a COVID-19 vaccine, to move its operations to the US.


US, COVID-19, vaccine, Germany, President Donald Trump, CureVac, messenger RNA, mRNA

LSIPR